

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 5.72660722 |
| 2 | muscle filament sliding (GO:0030049) | 5.72660722 |
| 3 | hemidesmosome assembly (GO:0031581) | 5.36827479 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.30420782 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 5.30420782 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.22110637 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 5.22110637 |
| 8 | lysine catabolic process (GO:0006554) | 5.00248733 |
| 9 | lysine metabolic process (GO:0006553) | 5.00248733 |
| 10 | actin-mediated cell contraction (GO:0070252) | 4.99469609 |
| 11 | aspartate family amino acid catabolic process (GO:0009068) | 4.82725172 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 4.81370513 |
| 13 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.77724230 |
| 14 | glyoxylate metabolic process (GO:0046487) | 4.77679347 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.74821721 |
| 16 | desmosome organization (GO:0002934) | 4.59778955 |
| 17 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.44848763 |
| 18 | aromatic amino acid family catabolic process (GO:0009074) | 4.32533888 |
| 19 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.31649898 |
| 20 | kynurenine metabolic process (GO:0070189) | 4.28927312 |
| 21 | 2-oxoglutarate metabolic process (GO:0006103) | 4.11195933 |
| 22 | actin filament-based movement (GO:0030048) | 4.07844683 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 3.98108395 |
| 24 | bile acid biosynthetic process (GO:0006699) | 3.95128169 |
| 25 | amino-acid betaine metabolic process (GO:0006577) | 3.94636021 |
| 26 | glutamate metabolic process (GO:0006536) | 3.90440559 |
| 27 | short-chain fatty acid metabolic process (GO:0046459) | 3.89015241 |
| 28 | high-density lipoprotein particle remodeling (GO:0034375) | 3.88253686 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 3.87949812 |
| 30 | carnitine shuttle (GO:0006853) | 3.87576522 |
| 31 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.86114094 |
| 32 | cysteine metabolic process (GO:0006534) | 3.85685377 |
| 33 | acetyl-CoA metabolic process (GO:0006084) | 3.84192636 |
| 34 | cell-substrate junction assembly (GO:0007044) | 3.83585476 |
| 35 | skeletal muscle contraction (GO:0003009) | 3.83387770 |
| 36 | fatty acid transmembrane transport (GO:1902001) | 3.83071634 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 3.82967974 |
| 38 | fatty acid beta-oxidation (GO:0006635) | 3.82369675 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 3.81697987 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.78931446 |
| 41 | cellular ketone body metabolic process (GO:0046950) | 3.73474373 |
| 42 | dicarboxylic acid catabolic process (GO:0043649) | 3.71133521 |
| 43 | striated muscle contraction (GO:0006941) | 3.70084030 |
| 44 | alpha-amino acid catabolic process (GO:1901606) | 3.69949044 |
| 45 | regulation of skeletal muscle contraction (GO:0014819) | 3.67127452 |
| 46 | actomyosin structure organization (GO:0031032) | 3.66659634 |
| 47 | homocysteine metabolic process (GO:0050667) | 3.64527258 |
| 48 | ethanol oxidation (GO:0006069) | 3.63754052 |
| 49 | regulation of relaxation of muscle (GO:1901077) | 3.63675276 |
| 50 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.59524208 |
| 51 | regulation of fibrinolysis (GO:0051917) | 3.59233954 |
| 52 | cellular modified amino acid catabolic process (GO:0042219) | 3.55275406 |
| 53 | sarcomere organization (GO:0045214) | 3.54066790 |
| 54 | cardiac muscle contraction (GO:0060048) | 3.52444044 |
| 55 | reverse cholesterol transport (GO:0043691) | 3.52037214 |
| 56 | regulation of protein activation cascade (GO:2000257) | 3.51504172 |
| 57 | fatty acid oxidation (GO:0019395) | 3.50833031 |
| 58 | cellular amino acid catabolic process (GO:0009063) | 3.49929407 |
| 59 | tryptophan catabolic process (GO:0006569) | 3.49850537 |
| 60 | indole-containing compound catabolic process (GO:0042436) | 3.49850537 |
| 61 | indolalkylamine catabolic process (GO:0046218) | 3.49850537 |
| 62 | protein-lipid complex remodeling (GO:0034368) | 3.49651066 |
| 63 | macromolecular complex remodeling (GO:0034367) | 3.49651066 |
| 64 | plasma lipoprotein particle remodeling (GO:0034369) | 3.49651066 |
| 65 | carnitine metabolic process (GO:0009437) | 3.49573032 |
| 66 | protein carboxylation (GO:0018214) | 3.48667047 |
| 67 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.48667047 |
| 68 | lipid oxidation (GO:0034440) | 3.47405426 |
| 69 | glycine metabolic process (GO:0006544) | 3.46512253 |
| 70 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.46182648 |
| 71 | coenzyme catabolic process (GO:0009109) | 3.44740806 |
| 72 | fatty acid catabolic process (GO:0009062) | 3.41477196 |
| 73 | positive regulation of fatty acid oxidation (GO:0046321) | 3.40226493 |
| 74 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.40018887 |
| 75 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.39816433 |
| 76 | regulation of cholesterol esterification (GO:0010872) | 3.39457058 |
| 77 | plasma lipoprotein particle clearance (GO:0034381) | 3.34862010 |
| 78 | negative regulation of sterol transport (GO:0032372) | 3.34180542 |
| 79 | negative regulation of cholesterol transport (GO:0032375) | 3.34180542 |
| 80 | tricarboxylic acid cycle (GO:0006099) | 3.31118949 |
| 81 | urea cycle (GO:0000050) | 3.31004989 |
| 82 | urea metabolic process (GO:0019627) | 3.31004989 |
| 83 | regulation of actin filament-based movement (GO:1903115) | 3.30425891 |
| 84 | monocarboxylic acid catabolic process (GO:0072329) | 3.30190289 |
| 85 | cardiac myofibril assembly (GO:0055003) | 3.29987553 |
| 86 | bile acid metabolic process (GO:0008206) | 3.29891099 |
| 87 | regulation of cholesterol homeostasis (GO:2000188) | 3.29354419 |
| 88 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.28726680 |
| 89 | regulation of complement activation (GO:0030449) | 3.28656765 |
| 90 | tryptophan metabolic process (GO:0006568) | 3.28594942 |
| 91 | ketone body metabolic process (GO:1902224) | 3.28444162 |
| 92 | acylglycerol homeostasis (GO:0055090) | 3.27608544 |
| 93 | triglyceride homeostasis (GO:0070328) | 3.27608544 |
| 94 | regulation of fatty acid oxidation (GO:0046320) | 3.26879318 |
| 95 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.25788991 |
| 96 | biotin metabolic process (GO:0006768) | 3.24705660 |
| 97 | serine family amino acid metabolic process (GO:0009069) | 3.24316874 |
| 98 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.23093998 |
| 99 | phospholipid homeostasis (GO:0055091) | 3.20322964 |
| 100 | cell-substrate adherens junction assembly (GO:0007045) | 3.19033117 |
| 101 | focal adhesion assembly (GO:0048041) | 3.19033117 |
| 102 | complement activation, alternative pathway (GO:0006957) | 3.18325195 |
| 103 | regulation of the force of heart contraction (GO:0002026) | 3.18269879 |
| 104 | response to muscle activity (GO:0014850) | 3.18087049 |
| 105 | carboxylic acid catabolic process (GO:0046395) | 3.15783406 |
| 106 | organic acid catabolic process (GO:0016054) | 3.15783406 |
| 107 | serine family amino acid biosynthetic process (GO:0009070) | 3.14072224 |
| 108 | positive regulation of lipid catabolic process (GO:0050996) | 3.12621710 |
| 109 | branched-chain amino acid catabolic process (GO:0009083) | 3.12569369 |
| 110 | fatty acid homeostasis (GO:0055089) | 3.10385042 |
| 111 | sodium ion export (GO:0071436) | 3.09898075 |
| 112 | striated muscle hypertrophy (GO:0014897) | 3.09791285 |
| 113 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.07181517 |
| 114 | aromatic amino acid family metabolic process (GO:0009072) | 3.06681610 |
| 115 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.06662712 |
| 116 | tyrosine metabolic process (GO:0006570) | 3.06260668 |
| 117 | muscle contraction (GO:0006936) | 3.04962336 |
| 118 | carnitine transmembrane transport (GO:1902603) | 3.04683854 |
| 119 | adherens junction assembly (GO:0034333) | 3.03913804 |
| 120 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.02865985 |
| 121 | skeletal muscle adaptation (GO:0043501) | 3.02865858 |
| 122 | plasma membrane repair (GO:0001778) | 3.02638277 |
| 123 | regulation of cell communication by electrical coupling (GO:0010649) | 3.02442712 |
| 124 | regulation of cholesterol metabolic process (GO:0090181) | 3.02310722 |
| 125 | nitrogen cycle metabolic process (GO:0071941) | 3.01938250 |
| 126 | myofibril assembly (GO:0030239) | 3.00832821 |
| 127 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.98249257 |
| 128 | creatine metabolic process (GO:0006600) | 2.97224044 |
| 129 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.95771127 |
| 130 | cell communication involved in cardiac conduction (GO:0086065) | 2.95751401 |
| 131 | low-density lipoprotein particle remodeling (GO:0034374) | 2.95675031 |
| 132 | amino-acid betaine transport (GO:0015838) | 2.95475445 |
| 133 | carnitine transport (GO:0015879) | 2.95475445 |
| 134 | cardiac muscle hypertrophy (GO:0003300) | 2.92853123 |
| 135 | negative regulation of protein localization to cell surface (GO:2000009) | 2.92107123 |
| 136 | NADH metabolic process (GO:0006734) | 2.91840833 |
| 137 | epithelial cell-cell adhesion (GO:0090136) | 2.82399963 |
| 138 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.81124949 |
| 139 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.77372968 |
| 140 | keratinocyte proliferation (GO:0043616) | 2.75633054 |
| 141 | cell communication by electrical coupling (GO:0010644) | 2.75417901 |
| 142 | skeletal muscle fiber development (GO:0048741) | 2.74201081 |
| 143 | muscle tissue morphogenesis (GO:0060415) | 2.74099537 |
| 144 | myoblast fusion (GO:0007520) | 2.73120331 |
| 145 | muscle system process (GO:0003012) | 2.72672946 |
| 146 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.70823083 |
| 147 | skin morphogenesis (GO:0043589) | 2.69510369 |
| 148 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.64922795 |
| 149 | muscle hypertrophy (GO:0014896) | 2.62300689 |
| 150 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.61733202 |
| 151 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.56865331 |
| 152 | cell adhesion mediated by integrin (GO:0033627) | 2.56398193 |
| 153 | endodermal cell differentiation (GO:0035987) | 2.55299921 |
| 154 | response to inactivity (GO:0014854) | 2.54894428 |
| 155 | striated muscle adaptation (GO:0014888) | 2.54146997 |
| 156 | muscle cell fate commitment (GO:0042693) | 2.52864958 |
| 157 | glomerular basement membrane development (GO:0032836) | 2.51257634 |
| 158 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.45946763 |
| 159 | cardiac muscle cell development (GO:0055013) | 2.45644783 |
| 160 | actin filament depolymerization (GO:0030042) | 2.44626467 |
| 161 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.44199934 |
| 162 | myotube cell development (GO:0014904) | 2.44107007 |
| 163 | atrioventricular valve morphogenesis (GO:0003181) | 2.43256646 |
| 164 | relaxation of cardiac muscle (GO:0055119) | 2.43239815 |
| 165 | regulation of p38MAPK cascade (GO:1900744) | 2.41740284 |
| 166 | cardiac cell development (GO:0055006) | 2.41093395 |
| 167 | cellular potassium ion homeostasis (GO:0030007) | 2.39899857 |
| 168 | regulation of protein localization to cell surface (GO:2000008) | 2.39475702 |
| 169 | relaxation of muscle (GO:0090075) | 2.38415391 |
| 170 | gap junction assembly (GO:0016264) | 2.38343699 |
| 171 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.37715886 |
| 172 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.36716431 |
| 173 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.36111459 |
| 174 | regulation of striated muscle contraction (GO:0006942) | 2.35240986 |
| 175 | skeletal muscle tissue development (GO:0007519) | 2.34795637 |
| 176 | myelination in peripheral nervous system (GO:0022011) | 2.34523895 |
| 177 | peripheral nervous system axon ensheathment (GO:0032292) | 2.34523895 |
| 178 | hypotonic response (GO:0006971) | 2.32586560 |
| 179 | Golgi transport vesicle coating (GO:0048200) | 2.30358941 |
| 180 | COPI coating of Golgi vesicle (GO:0048205) | 2.30358941 |
| 181 | negative regulation of inclusion body assembly (GO:0090084) | 2.29275613 |
| 182 | muscle cell cellular homeostasis (GO:0046716) | 2.27841825 |
| 183 | regulation of cardioblast differentiation (GO:0051890) | 2.27718029 |
| 184 | glycogen catabolic process (GO:0005980) | 2.26806857 |
| 185 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.25470266 |
| 186 | multicellular organismal water homeostasis (GO:0050891) | 2.25182378 |
| 187 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.24547956 |
| 188 | cell migration involved in heart development (GO:0060973) | 2.22283334 |
| 189 | heart trabecula formation (GO:0060347) | 2.21502052 |
| 190 | cardiac muscle adaptation (GO:0014887) | 2.19791456 |
| 191 | muscle hypertrophy in response to stress (GO:0003299) | 2.19791456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.41959802 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.68430968 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.49147822 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.07777475 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.66003438 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.63414400 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.56198700 |
| 8 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.26449225 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.74772453 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.28165247 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.21297373 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.19682313 |
| 13 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.14536757 |
| 14 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.11945447 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.03999265 |
| 16 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.94186247 |
| 17 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.84516108 |
| 18 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.81898198 |
| 19 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.79389516 |
| 20 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.78056616 |
| 21 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.78056616 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.73195219 |
| 23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.72616868 |
| 24 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.72122784 |
| 25 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.67898820 |
| 26 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.67469489 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.67313270 |
| 28 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.62666864 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.52709485 |
| 30 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.49587683 |
| 31 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.46194815 |
| 32 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.46194815 |
| 33 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.45581224 |
| 34 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.43832069 |
| 35 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.43645671 |
| 36 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.36757547 |
| 37 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.32598077 |
| 38 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31217419 |
| 39 | CJUN_26792858_Chip-Seq_BT549_Human | 1.24669354 |
| 40 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.22439611 |
| 41 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.21631794 |
| 42 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17840233 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17649808 |
| 44 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.17463992 |
| 45 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.15948005 |
| 46 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.15406357 |
| 47 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.15406357 |
| 48 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.14614806 |
| 49 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14308478 |
| 50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13252840 |
| 51 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.12979109 |
| 52 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.11708078 |
| 53 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.11538143 |
| 54 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.11126710 |
| 55 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10639251 |
| 56 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.09832523 |
| 57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09196242 |
| 58 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.08941027 |
| 59 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.07952141 |
| 60 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.06836139 |
| 61 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06719649 |
| 62 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06514099 |
| 63 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.05761001 |
| 64 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05634069 |
| 65 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03935085 |
| 66 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.03474938 |
| 67 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.03441287 |
| 68 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.03357862 |
| 69 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02979184 |
| 70 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.02747606 |
| 71 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.02503571 |
| 72 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.02254810 |
| 73 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.01865218 |
| 74 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01623648 |
| 75 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01341584 |
| 76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00981859 |
| 77 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.00799173 |
| 78 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.00706905 |
| 79 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.98557852 |
| 80 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.98434296 |
| 81 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98329363 |
| 82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97554914 |
| 83 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.97418194 |
| 84 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97141349 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96322353 |
| 86 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.96223134 |
| 87 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.96172148 |
| 88 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.93841680 |
| 89 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.93629403 |
| 90 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.93431467 |
| 91 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93277045 |
| 92 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.93012830 |
| 93 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92031842 |
| 94 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.91826768 |
| 95 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91818166 |
| 96 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.91016036 |
| 97 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.90965469 |
| 98 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.90873471 |
| 99 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.89599687 |
| 100 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.89583853 |
| 101 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.89228701 |
| 102 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.88558731 |
| 103 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88074798 |
| 104 | ATF3_27146783_Chip-Seq_COLON_Human | 0.84966997 |
| 105 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84612882 |
| 106 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.84419543 |
| 107 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.83371336 |
| 108 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.83213283 |
| 109 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.82284191 |
| 110 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.81813452 |
| 111 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.80892020 |
| 112 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.80131595 |
| 113 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.78648879 |
| 114 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78375339 |
| 115 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.78326010 |
| 116 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.77705021 |
| 117 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.76937608 |
| 118 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.76904022 |
| 119 | KDM2B_26808549_Chip-Seq_K562_Human | 0.76840306 |
| 120 | TP53_16413492_ChIP-PET_HCT116_Human | 0.76192160 |
| 121 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.75876807 |
| 122 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.75683513 |
| 123 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.75637279 |
| 124 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75182841 |
| 125 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75182841 |
| 126 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.74813842 |
| 127 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.74371427 |
| 128 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74295957 |
| 129 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.73201087 |
| 130 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73140267 |
| 131 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.72706447 |
| 132 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.71836033 |
| 133 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71271438 |
| 134 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.69220573 |
| 135 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.68640397 |
| 136 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.68187677 |
| 137 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.68032003 |
| 138 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.66740756 |
| 139 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.65460159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.16381368 |
| 2 | MP0005360_urolithiasis | 4.56470188 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.12182803 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.69154549 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.67067946 |
| 6 | MP0005365_abnormal_bile_salt | 3.62235867 |
| 7 | MP0000751_myopathy | 2.88211842 |
| 8 | MP0003646_muscle_fatigue | 2.81529397 |
| 9 | MP0004084_abnormal_cardiac_muscle | 2.74835316 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.72801992 |
| 11 | MP0009840_abnormal_foam_cell | 2.63764929 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.63735004 |
| 13 | MP0003252_abnormal_bile_duct | 2.62202280 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.52449274 |
| 15 | MP0003941_abnormal_skin_development | 2.44119174 |
| 16 | MP0004215_abnormal_myocardial_fiber | 2.40043397 |
| 17 | MP0000749_muscle_degeneration | 2.36933195 |
| 18 | MP0005330_cardiomyopathy | 2.35843669 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.33920786 |
| 20 | MP0004036_abnormal_muscle_relaxation | 2.26392989 |
| 21 | MP0005332_abnormal_amino_acid | 2.18844471 |
| 22 | MP0005083_abnormal_biliary_tract | 2.10006058 |
| 23 | MP0004130_abnormal_muscle_cell | 2.06068987 |
| 24 | MP0004087_abnormal_muscle_fiber | 2.05680738 |
| 25 | MP0000762_abnormal_tongue_morphology | 2.00835148 |
| 26 | MP0002269_muscular_atrophy | 1.97390130 |
| 27 | MP0005257_abnormal_intraocular_pressure | 1.82221452 |
| 28 | MP0000013_abnormal_adipose_tissue | 1.81325793 |
| 29 | MP0000747_muscle_weakness | 1.77852036 |
| 30 | MP0003195_calcinosis | 1.77556524 |
| 31 | MP0003137_abnormal_impulse_conducting | 1.73545632 |
| 32 | MP0005666_abnormal_adipose_tissue | 1.60510972 |
| 33 | MP0002972_abnormal_cardiac_muscle | 1.60027129 |
| 34 | MP0006138_congestive_heart_failure | 1.57775608 |
| 35 | MP0010234_abnormal_vibrissa_follicle | 1.56241217 |
| 36 | MP0004270_analgesia | 1.56041752 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.55713362 |
| 38 | MP0000566_synostosis | 1.54406175 |
| 39 | MP0000750_abnormal_muscle_regeneration | 1.53972326 |
| 40 | MP0005620_abnormal_muscle_contractility | 1.53689161 |
| 41 | MP0005023_abnormal_wound_healing | 1.53517002 |
| 42 | MP0010630_abnormal_cardiac_muscle | 1.53136460 |
| 43 | MP0008775_abnormal_heart_ventricle | 1.52017584 |
| 44 | MP0004145_abnormal_muscle_electrophysio | 1.48126728 |
| 45 | MP0005503_abnormal_tendon_morphology | 1.47579289 |
| 46 | MP0001666_abnormal_nutrient_absorption | 1.47014213 |
| 47 | MP0000467_abnormal_esophagus_morphology | 1.45928169 |
| 48 | MP0004233_abnormal_muscle_weight | 1.44046543 |
| 49 | MP0001958_emphysema | 1.41916904 |
| 50 | MP0004185_abnormal_adipocyte_glucose | 1.41123072 |
| 51 | MP0005670_abnormal_white_adipose | 1.40996673 |
| 52 | MP0002060_abnormal_skin_morphology | 1.40252358 |
| 53 | MP0003950_abnormal_plasma_membrane | 1.38895287 |
| 54 | MP0010030_abnormal_orbit_morphology | 1.38818865 |
| 55 | MP0005409_darkened_coat_color | 1.37973281 |
| 56 | MP0005385_cardiovascular_system_phenoty | 1.35953312 |
| 57 | MP0001544_abnormal_cardiovascular_syste | 1.35953312 |
| 58 | MP0005319_abnormal_enzyme/_coenzyme | 1.31831978 |
| 59 | MP0000759_abnormal_skeletal_muscle | 1.28617552 |
| 60 | MP0002106_abnormal_muscle_physiology | 1.27697179 |
| 61 | MP0003091_abnormal_cell_migration | 1.26875949 |
| 62 | MP0003690_abnormal_glial_cell | 1.26410644 |
| 63 | MP0000609_abnormal_liver_physiology | 1.24999091 |
| 64 | MP0009384_cardiac_valve_regurgitation | 1.23877004 |
| 65 | MP0006036_abnormal_mitochondrial_physio | 1.21746140 |
| 66 | MP0000003_abnormal_adipose_tissue | 1.17851432 |
| 67 | MP0001849_ear_inflammation | 1.15191752 |
| 68 | MP0003191_abnormal_cellular_cholesterol | 1.13379070 |
| 69 | MP0005623_abnormal_meninges_morphology | 1.12196117 |
| 70 | MP0005369_muscle_phenotype | 1.11430919 |
| 71 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09609470 |
| 72 | MP0002896_abnormal_bone_mineralization | 1.08811575 |
| 73 | MP0004484_altered_response_of | 1.08174081 |
| 74 | MP0004043_abnormal_pH_regulation | 1.06698146 |
| 75 | MP0003329_amyloid_beta_deposits | 1.06184604 |
| 76 | MP0004510_myositis | 1.04551708 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 1.04129341 |
| 78 | MP0004019_abnormal_vitamin_homeostasis | 1.00888423 |
| 79 | MP0005266_abnormal_metabolism | 1.00387379 |
| 80 | MP0004085_abnormal_heartbeat | 0.99992838 |
| 81 | MP0005375_adipose_tissue_phenotype | 0.99431472 |
| 82 | MP0002971_abnormal_brown_adipose | 0.98405425 |
| 83 | MP0002332_abnormal_exercise_endurance | 0.96777251 |
| 84 | MP0003045_fibrosis | 0.94941029 |
| 85 | MP0010352_gastrointestinal_tract_polyps | 0.93672348 |
| 86 | MP0010368_abnormal_lymphatic_system | 0.90971638 |
| 87 | MP0005451_abnormal_body_composition | 0.90324356 |
| 88 | MP0006035_abnormal_mitochondrial_morpho | 0.87283316 |
| 89 | MP0000767_abnormal_smooth_muscle | 0.86513714 |
| 90 | MP0000579_abnormal_nail_morphology | 0.85846316 |
| 91 | MP0002108_abnormal_muscle_morphology | 0.85347185 |
| 92 | MP0008438_abnormal_cutaneous_collagen | 0.83837254 |
| 93 | MP0004272_abnormal_basement_membrane | 0.81615642 |
| 94 | MP0000534_abnormal_ureter_morphology | 0.81228485 |
| 95 | MP0003879_abnormal_hair_cell | 0.79769861 |
| 96 | MP0002254_reproductive_system_inflammat | 0.79743521 |
| 97 | MP0003279_aneurysm | 0.77335772 |
| 98 | MP0003566_abnormal_cell_adhesion | 0.76896396 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.76299876 |
| 100 | MP0000462_abnormal_digestive_system | 0.75388233 |
| 101 | MP0005165_increased_susceptibility_to | 0.75230907 |
| 102 | MP0010678_abnormal_skin_adnexa | 0.74862750 |
| 103 | MP0002127_abnormal_cardiovascular_syste | 0.74124852 |
| 104 | MP0003221_abnormal_cardiomyocyte_apopto | 0.72096736 |
| 105 | MP0003868_abnormal_feces_composition | 0.71563181 |
| 106 | MP0000733_abnormal_muscle_development | 0.71395869 |
| 107 | MP0005501_abnormal_skin_physiology | 0.71345929 |
| 108 | MP0004885_abnormal_endolymph | 0.70632911 |
| 109 | MP0004134_abnormal_chest_morphology | 0.70292441 |
| 110 | MP0009250_abnormal_appendicular_skeleto | 0.69936756 |
| 111 | MP0004858_abnormal_nervous_system | 0.69557684 |
| 112 | MP0009672_abnormal_birth_weight | 0.69269281 |
| 113 | MP0005187_abnormal_penis_morphology | 0.68982578 |
| 114 | MP0000604_amyloidosis | 0.68778529 |
| 115 | MP0005508_abnormal_skeleton_morphology | 0.68403674 |
| 116 | MP0008569_lethality_at_weaning | 0.68317781 |
| 117 | MP0009053_abnormal_anal_canal | 0.67632003 |
| 118 | MP0009643_abnormal_urine_homeostasis | 0.67133877 |
| 119 | MP0001216_abnormal_epidermal_layer | 0.65730642 |
| 120 | MP0002128_abnormal_blood_circulation | 0.64829654 |
| 121 | MP0002098_abnormal_vibrissa_morphology | 0.64759472 |
| 122 | MP0000266_abnormal_heart_morphology | 0.64730047 |
| 123 | MP0003011_delayed_dark_adaptation | 0.64536070 |
| 124 | MP0002168_other_aberrant_phenotype | 0.63416224 |
| 125 | MP0002089_abnormal_postnatal_growth/wei | 0.62760902 |
| 126 | MP0002078_abnormal_glucose_homeostasis | 0.62734913 |
| 127 | MP0003632_abnormal_nervous_system | 0.62386392 |
| 128 | MP0003656_abnormal_erythrocyte_physiolo | 0.62276123 |
| 129 | MP0003828_pulmonary_edema | 0.61815266 |
| 130 | MP0004859_abnormal_synaptic_plasticity | 0.61655844 |
| 131 | MP0000598_abnormal_liver_morphology | 0.61159409 |
| 132 | MP0002138_abnormal_hepatobiliary_system | 0.60972368 |
| 133 | MP0000383_abnormal_hair_follicle | 0.60971279 |
| 134 | MP0000920_abnormal_myelination | 0.60899272 |
| 135 | MP0005423_abnormal_somatic_nervous | 0.59861749 |
| 136 | MP0001661_extended_life_span | 0.59854893 |
| 137 | MP0010771_integument_phenotype | 0.59038614 |
| 138 | MP0002295_abnormal_pulmonary_circulatio | 0.57166896 |
| 139 | MP0005275_abnormal_skin_tensile | 0.57019264 |
| 140 | MP0005647_abnormal_sex_gland | 0.54209331 |
| 141 | MP0002796_impaired_skin_barrier | 0.52885372 |
| 142 | MP0003186_abnormal_redox_activity | 0.52466839 |
| 143 | MP0002234_abnormal_pharynx_morphology | 0.52011874 |
| 144 | MP0001299_abnormal_eye_distance/ | 0.51636802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 6.63668968 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.84769329 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.65071630 |
| 4 | Xanthomatosis (HP:0000991) | 4.36418220 |
| 5 | Sudden death (HP:0001699) | 4.20851164 |
| 6 | Exercise-induced myalgia (HP:0003738) | 4.08970642 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.08016225 |
| 8 | Myoglobinuria (HP:0002913) | 4.07565448 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.03660669 |
| 10 | Exercise-induced muscle cramps (HP:0003710) | 4.01162733 |
| 11 | Hyperammonemia (HP:0001987) | 4.00529056 |
| 12 | Hypoalphalipoproteinemia (HP:0003233) | 3.96617919 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.83289258 |
| 14 | Ketosis (HP:0001946) | 3.80988750 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 3.75695733 |
| 16 | Round ear (HP:0100830) | 3.66248421 |
| 17 | Hypoglycemic coma (HP:0001325) | 3.65253467 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.63620174 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 3.63620174 |
| 20 | Hyperglycinuria (HP:0003108) | 3.62136353 |
| 21 | Muscle fiber splitting (HP:0003555) | 3.55849342 |
| 22 | Hypolipoproteinemia (HP:0010981) | 3.51300767 |
| 23 | Ketoacidosis (HP:0001993) | 3.50638968 |
| 24 | Distal arthrogryposis (HP:0005684) | 3.48916494 |
| 25 | Calf muscle hypertrophy (HP:0008981) | 3.44443080 |
| 26 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.43069745 |
| 27 | Hyperglycinemia (HP:0002154) | 3.42848823 |
| 28 | Right ventricular cardiomyopathy (HP:0011663) | 3.39513656 |
| 29 | Neck muscle weakness (HP:0000467) | 3.38584412 |
| 30 | Hypobetalipoproteinemia (HP:0003563) | 3.35424326 |
| 31 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.34857417 |
| 32 | Ventricular tachycardia (HP:0004756) | 3.32620256 |
| 33 | Myopathic facies (HP:0002058) | 3.31831223 |
| 34 | Atrophic scars (HP:0001075) | 3.28353428 |
| 35 | Protrusio acetabuli (HP:0003179) | 3.22490556 |
| 36 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.22373747 |
| 37 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.16368763 |
| 38 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.13660310 |
| 39 | Premature rupture of membranes (HP:0001788) | 3.13292767 |
| 40 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.00510527 |
| 41 | Increased connective tissue (HP:0009025) | 2.99754759 |
| 42 | Abnormality of the calf musculature (HP:0001430) | 2.96058671 |
| 43 | Ulnar deviation of the wrist (HP:0003049) | 2.95080410 |
| 44 | Spinal rigidity (HP:0003306) | 2.94258517 |
| 45 | Atrial fibrillation (HP:0005110) | 2.87821676 |
| 46 | Distal lower limb amyotrophy (HP:0008944) | 2.83982830 |
| 47 | Abnormality of methionine metabolism (HP:0010901) | 2.83509747 |
| 48 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.79913093 |
| 49 | Prolonged partial thromboplastin time (HP:0003645) | 2.79782918 |
| 50 | Epidermoid cyst (HP:0200040) | 2.79720641 |
| 51 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.78479572 |
| 52 | EMG: myopathic abnormalities (HP:0003458) | 2.73727263 |
| 53 | Rhabdomyolysis (HP:0003201) | 2.70412030 |
| 54 | Difficulty running (HP:0009046) | 2.68376984 |
| 55 | Complement deficiency (HP:0004431) | 2.63621321 |
| 56 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.63181108 |
| 57 | Arterial tortuosity (HP:0005116) | 2.61475626 |
| 58 | Lipoatrophy (HP:0100578) | 2.61040625 |
| 59 | Primary atrial arrhythmia (HP:0001692) | 2.59082566 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.56055595 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.56055595 |
| 62 | Vascular tortuosity (HP:0004948) | 2.54585221 |
| 63 | Atrioventricular block (HP:0001678) | 2.53258127 |
| 64 | Syncope (HP:0001279) | 2.52189062 |
| 65 | Skin nodule (HP:0200036) | 2.51185485 |
| 66 | Cholelithiasis (HP:0001081) | 2.48587319 |
| 67 | Aortic aneurysm (HP:0004942) | 2.45995385 |
| 68 | Fragile skin (HP:0001030) | 2.44730491 |
| 69 | Supraventricular tachycardia (HP:0004755) | 2.44654878 |
| 70 | Supraventricular arrhythmia (HP:0005115) | 2.42588780 |
| 71 | Dilated cardiomyopathy (HP:0001644) | 2.41050911 |
| 72 | Popliteal pterygium (HP:0009756) | 2.39039640 |
| 73 | Abnormality of serum amino acid levels (HP:0003112) | 2.37531702 |
| 74 | Delayed CNS myelination (HP:0002188) | 2.36788906 |
| 75 | Abnormal gallbladder morphology (HP:0012437) | 2.33514642 |
| 76 | Bundle branch block (HP:0011710) | 2.33288342 |
| 77 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.33047179 |
| 78 | Ventricular arrhythmia (HP:0004308) | 2.32470755 |
| 79 | Calcaneovalgus deformity (HP:0001848) | 2.32404801 |
| 80 | Lower limb amyotrophy (HP:0007210) | 2.31993639 |
| 81 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.31409922 |
| 82 | Heart block (HP:0012722) | 2.31259213 |
| 83 | Broad metatarsal (HP:0001783) | 2.29775984 |
| 84 | Abnormality of the Achilles tendon (HP:0005109) | 2.29074863 |
| 85 | Rimmed vacuoles (HP:0003805) | 2.28486562 |
| 86 | Scapular winging (HP:0003691) | 2.27967704 |
| 87 | Subaortic stenosis (HP:0001682) | 2.27102278 |
| 88 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.27102278 |
| 89 | Aortic dissection (HP:0002647) | 2.23359072 |
| 90 | Abnormality of the common coagulation pathway (HP:0010990) | 2.20506968 |
| 91 | Muscle stiffness (HP:0003552) | 2.20010252 |
| 92 | Abnormal atrioventricular conduction (HP:0005150) | 2.19724265 |
| 93 | Milia (HP:0001056) | 2.19580505 |
| 94 | Limb-girdle muscle atrophy (HP:0003797) | 2.19370578 |
| 95 | Absent phalangeal crease (HP:0006109) | 2.18049731 |
| 96 | Palpitations (HP:0001962) | 2.16563266 |
| 97 | Metabolic acidosis (HP:0001942) | 2.15878581 |
| 98 | EMG: neuropathic changes (HP:0003445) | 2.15460100 |
| 99 | Type 1 muscle fiber predominance (HP:0003803) | 2.13769461 |
| 100 | Asymmetric septal hypertrophy (HP:0001670) | 2.12612395 |
| 101 | Slender build (HP:0001533) | 2.11862092 |
| 102 | Cerebral edema (HP:0002181) | 2.07615147 |
| 103 | Pterygium (HP:0001059) | 2.06942772 |
| 104 | Turricephaly (HP:0000262) | 2.06817609 |
| 105 | Hypercholesterolemia (HP:0003124) | 2.04649117 |
| 106 | Abnormality of the neuromuscular junction (HP:0003398) | 2.04160099 |
| 107 | Fatigable weakness (HP:0003473) | 2.04160099 |
| 108 | Gowers sign (HP:0003391) | 2.03640202 |
| 109 | Deformed tarsal bones (HP:0008119) | 2.03408333 |
| 110 | Frequent falls (HP:0002359) | 2.02661956 |
| 111 | Hip contracture (HP:0003273) | 2.01497034 |
| 112 | Lethargy (HP:0001254) | 2.01311828 |
| 113 | Muscle fiber inclusion bodies (HP:0100299) | 1.98681915 |
| 114 | Back pain (HP:0003418) | 1.97369031 |
| 115 | Foot dorsiflexor weakness (HP:0009027) | 1.96821887 |
| 116 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.96203803 |
| 117 | Prolonged QT interval (HP:0001657) | 1.95390131 |
| 118 | Fat malabsorption (HP:0002630) | 1.95322174 |
| 119 | Gout (HP:0001997) | 1.94831495 |
| 120 | Cerebral aneurysm (HP:0004944) | 1.94237605 |
| 121 | Increased variability in muscle fiber diameter (HP:0003557) | 1.93655366 |
| 122 | Abnormality of the foot musculature (HP:0001436) | 1.93113369 |
| 123 | Hyperkalemia (HP:0002153) | 1.92586158 |
| 124 | Generalized muscle weakness (HP:0003324) | 1.91870345 |
| 125 | Achilles tendon contracture (HP:0001771) | 1.91238470 |
| 126 | Myotonia (HP:0002486) | 1.88491933 |
| 127 | Spastic diplegia (HP:0001264) | 1.87277553 |
| 128 | Areflexia of lower limbs (HP:0002522) | 1.87057448 |
| 129 | Late onset (HP:0003584) | 1.86630526 |
| 130 | Pseudobulbar signs (HP:0002200) | 1.86092293 |
| 131 | Difficulty climbing stairs (HP:0003551) | 1.85977935 |
| 132 | Shallow orbits (HP:0000586) | 1.85901975 |
| 133 | Abnormality of nail color (HP:0100643) | 1.84584241 |
| 134 | Ragged-red muscle fibers (HP:0003200) | 1.84257394 |
| 135 | Limited hip movement (HP:0008800) | 1.84204940 |
| 136 | Hepatocellular carcinoma (HP:0001402) | 1.83578356 |
| 137 | Abnormal gallbladder physiology (HP:0012438) | 1.83512483 |
| 138 | Cholecystitis (HP:0001082) | 1.83512483 |
| 139 | Abnormality of the intrinsic pathway (HP:0010989) | 1.83051822 |
| 140 | Abnormality of the salivary glands (HP:0010286) | 1.81252882 |
| 141 | Malignant hyperthermia (HP:0002047) | 1.81164095 |
| 142 | Joint hemorrhage (HP:0005261) | 1.80292595 |
| 143 | Hyperbilirubinemia (HP:0002904) | 1.79737588 |
| 144 | Abnormality of complement system (HP:0005339) | 1.79185306 |
| 145 | Distal lower limb muscle weakness (HP:0009053) | 1.78752417 |
| 146 | Hypoglycemic seizures (HP:0002173) | 1.78374568 |
| 147 | Dysmetric saccades (HP:0000641) | 1.77495603 |
| 148 | Abnormal finger flexion creases (HP:0006143) | 1.76162044 |
| 149 | Onycholysis (HP:0001806) | 1.74672544 |
| 150 | Muscular dystrophy (HP:0003560) | 1.73738502 |
| 151 | Stridor (HP:0010307) | 1.72576840 |
| 152 | Ulnar bowing (HP:0003031) | 1.70978907 |
| 153 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.70531184 |
| 154 | Bulbar palsy (HP:0001283) | 1.69702591 |
| 155 | Fetal akinesia sequence (HP:0001989) | 1.69162355 |
| 156 | Distal upper limb amyotrophy (HP:0007149) | 1.67457130 |
| 157 | Upper limb amyotrophy (HP:0009129) | 1.67457130 |
| 158 | Abnormality of the calcaneus (HP:0008364) | 1.65702927 |
| 159 | Breech presentation (HP:0001623) | 1.65210872 |
| 160 | Obstructive sleep apnea (HP:0002870) | 1.64491571 |
| 161 | Advanced eruption of teeth (HP:0006288) | 1.63921534 |
| 162 | Limb-girdle muscle weakness (HP:0003325) | 1.63556485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.28261727 |
| 2 | BCKDK | 3.85168815 |
| 3 | TRIB3 | 3.48946354 |
| 4 | PKN2 | 3.18730405 |
| 5 | PHKG2 | 2.98940945 |
| 6 | PHKG1 | 2.98940945 |
| 7 | SIK1 | 2.75317879 |
| 8 | OBSCN | 2.55937860 |
| 9 | LATS1 | 2.35590976 |
| 10 | LMTK2 | 2.32923264 |
| 11 | NEK1 | 2.14994008 |
| 12 | PDK4 | 1.94091402 |
| 13 | PDK3 | 1.94091402 |
| 14 | MAPK15 | 1.71612019 |
| 15 | PDGFRA | 1.69149334 |
| 16 | ERN1 | 1.67062691 |
| 17 | RIPK1 | 1.66978267 |
| 18 | MAPKAPK3 | 1.64671649 |
| 19 | PINK1 | 1.63703016 |
| 20 | EPHB1 | 1.57697873 |
| 21 | MET | 1.57434936 |
| 22 | DMPK | 1.52486371 |
| 23 | ICK | 1.44523207 |
| 24 | LIMK1 | 1.42757709 |
| 25 | LATS2 | 1.42026319 |
| 26 | PTK6 | 1.40567014 |
| 27 | PAK3 | 1.32421058 |
| 28 | FGFR2 | 1.24756741 |
| 29 | MAP3K7 | 1.22724515 |
| 30 | FGFR4 | 1.21648252 |
| 31 | PRKD1 | 1.18533121 |
| 32 | PIK3CA | 1.13227841 |
| 33 | TESK1 | 1.12293891 |
| 34 | MUSK | 1.10840570 |
| 35 | ERBB4 | 1.08516623 |
| 36 | PDK2 | 1.07481948 |
| 37 | BMX | 1.06071359 |
| 38 | FLT3 | 1.05539101 |
| 39 | CAMK2D | 1.05445742 |
| 40 | MARK1 | 1.04049332 |
| 41 | MYLK | 1.03054421 |
| 42 | MAPK12 | 1.01026165 |
| 43 | MAP3K3 | 1.00384961 |
| 44 | EPHA2 | 0.97233754 |
| 45 | STK38L | 0.96756980 |
| 46 | STK38 | 0.96502259 |
| 47 | INSRR | 0.94291759 |
| 48 | PAK6 | 0.93740777 |
| 49 | CAMK2G | 0.92912035 |
| 50 | MAP2K4 | 0.91559710 |
| 51 | MOS | 0.90054006 |
| 52 | PAK4 | 0.88008690 |
| 53 | WNK1 | 0.87447063 |
| 54 | PRKAA2 | 0.87079014 |
| 55 | MTOR | 0.85492079 |
| 56 | PTK2 | 0.85118981 |
| 57 | EPHB2 | 0.84949482 |
| 58 | MAP3K2 | 0.83461499 |
| 59 | FGFR1 | 0.81893432 |
| 60 | DDR2 | 0.81479722 |
| 61 | ARAF | 0.81199542 |
| 62 | SMG1 | 0.79026665 |
| 63 | PRKAA1 | 0.78421864 |
| 64 | ROCK1 | 0.76366268 |
| 65 | STK39 | 0.76328450 |
| 66 | STK24 | 0.76131028 |
| 67 | MAP3K13 | 0.75880364 |
| 68 | ROCK2 | 0.75108245 |
| 69 | TYRO3 | 0.73430937 |
| 70 | PKN1 | 0.73393912 |
| 71 | TGFBR2 | 0.72976020 |
| 72 | CAMK1D | 0.72422752 |
| 73 | PIK3CG | 0.68316671 |
| 74 | MAP2K3 | 0.67953692 |
| 75 | MAPK7 | 0.66697442 |
| 76 | AKT2 | 0.65859256 |
| 77 | EPHA3 | 0.64574889 |
| 78 | MAPK11 | 0.63534055 |
| 79 | CDC42BPA | 0.62835078 |
| 80 | MAP3K6 | 0.62023561 |
| 81 | FER | 0.61227995 |
| 82 | CAMK4 | 0.60720915 |
| 83 | MAP2K1 | 0.60712249 |
| 84 | WNK4 | 0.59335963 |
| 85 | PDPK1 | 0.58453125 |
| 86 | TIE1 | 0.58366170 |
| 87 | CDK12 | 0.58161759 |
| 88 | PRKD2 | 0.57822614 |
| 89 | EEF2K | 0.57562683 |
| 90 | PRKD3 | 0.56079978 |
| 91 | MAP3K12 | 0.55167474 |
| 92 | MARK2 | 0.54938114 |
| 93 | CAMK1G | 0.54660888 |
| 94 | CAMK2A | 0.54102569 |
| 95 | PRKG2 | 0.53203124 |
| 96 | KSR2 | 0.53068250 |
| 97 | PRKACG | 0.52840460 |
| 98 | RPS6KA2 | 0.52577342 |
| 99 | TRPM7 | 0.51254092 |
| 100 | MAP3K9 | 0.51153587 |
| 101 | PAK2 | 0.50860890 |
| 102 | RET | 0.50859804 |
| 103 | PRKACB | 0.50475473 |
| 104 | GSK3A | 0.50250519 |
| 105 | ALK | 0.48954793 |
| 106 | CAMK2B | 0.48849202 |
| 107 | SGK3 | 0.47654686 |
| 108 | MAP3K10 | 0.46481127 |
| 109 | NEK9 | 0.45725187 |
| 110 | DAPK3 | 0.44229620 |
| 111 | SGK494 | 0.44222256 |
| 112 | SGK223 | 0.44222256 |
| 113 | TAOK2 | 0.44164839 |
| 114 | NEK6 | 0.43704124 |
| 115 | PTK2B | 0.43536814 |
| 116 | PRPF4B | 0.42501629 |
| 117 | ILK | 0.42296910 |
| 118 | ERBB2 | 0.41269384 |
| 119 | EPHA4 | 0.41089357 |
| 120 | RPS6KA3 | 0.40131754 |
| 121 | ABL2 | 0.40052236 |
| 122 | NTRK1 | 0.39239535 |
| 123 | LRRK2 | 0.39116052 |
| 124 | FGFR3 | 0.39056052 |
| 125 | PDGFRB | 0.38939880 |
| 126 | MST1R | 0.37918485 |
| 127 | CDK6 | 0.37671651 |
| 128 | AKT3 | 0.37518783 |
| 129 | CSNK1D | 0.37028764 |
| 130 | MAPK10 | 0.36588628 |
| 131 | DYRK1B | 0.34629701 |
| 132 | SGK2 | 0.33461187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.52690375 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.77141331 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.11246748 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.98986861 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.91091169 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.88634528 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.73546440 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.73459914 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.71463055 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.58846589 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.43365962 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.28732318 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.27146064 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.21684507 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.13577685 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.13304038 |
| 17 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.00543515 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91124642 |
| 19 | Carbon metabolism_Homo sapiens_hsa01200 | 1.84522680 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.73369513 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.69987382 |
| 22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.63495825 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.63120800 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.62189148 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.59438478 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.58568661 |
| 27 | Circadian rhythm_Homo sapiens_hsa04710 | 1.56088953 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.53982633 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.51357930 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.32001597 |
| 31 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27266465 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.24307183 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.24095706 |
| 34 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.24007807 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.21344722 |
| 36 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.20458524 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18488115 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.18119617 |
| 39 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.16986337 |
| 40 | Lysine degradation_Homo sapiens_hsa00310 | 1.16616220 |
| 41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.15291098 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.12133707 |
| 43 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.08460774 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.07372910 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.06596336 |
| 46 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.04514755 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.99304761 |
| 48 | Renin secretion_Homo sapiens_hsa04924 | 0.98569611 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 0.98383370 |
| 50 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.97131409 |
| 51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.96008435 |
| 52 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.95208476 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93041889 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.92704234 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.92293272 |
| 56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91975527 |
| 57 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.91935013 |
| 58 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.91306248 |
| 59 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.91071676 |
| 60 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.91005009 |
| 61 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.90828922 |
| 62 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.87775445 |
| 63 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.85757263 |
| 64 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.85304432 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85105985 |
| 66 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.83783596 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83243380 |
| 68 | Long-term potentiation_Homo sapiens_hsa04720 | 0.82119665 |
| 69 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79704361 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.79614494 |
| 71 | Insulin secretion_Homo sapiens_hsa04911 | 0.79387111 |
| 72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.77952680 |
| 73 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.73876661 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73625638 |
| 75 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.71873666 |
| 76 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.71553466 |
| 77 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68835671 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68790914 |
| 79 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68640848 |
| 80 | Melanogenesis_Homo sapiens_hsa04916 | 0.68127163 |
| 81 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.65345607 |
| 82 | Salivary secretion_Homo sapiens_hsa04970 | 0.62927659 |
| 83 | Gap junction_Homo sapiens_hsa04540 | 0.62539765 |
| 84 | Glioma_Homo sapiens_hsa05214 | 0.61420166 |
| 85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.61344373 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.59056293 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58084839 |
| 88 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56591490 |
| 89 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56529135 |
| 90 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.56479305 |
| 91 | Circadian entrainment_Homo sapiens_hsa04713 | 0.56247509 |
| 92 | Thyroid cancer_Homo sapiens_hsa05216 | 0.56206059 |
| 93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55737924 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55507075 |
| 95 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.54868701 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54497805 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.52787679 |
| 98 | Sulfur relay system_Homo sapiens_hsa04122 | 0.50743216 |
| 99 | Axon guidance_Homo sapiens_hsa04360 | 0.50718007 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.49430675 |
| 101 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.49196353 |
| 102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48316389 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48126474 |
| 104 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.48096083 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47426146 |
| 106 | Bladder cancer_Homo sapiens_hsa05219 | 0.47287402 |
| 107 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46005661 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44583115 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44306150 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44057121 |
| 111 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.42279796 |
| 112 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42165184 |
| 113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41511393 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.38715983 |
| 115 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.38568903 |
| 116 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33003158 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29576315 |
| 118 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28904439 |
| 119 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.28803328 |
| 120 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26794247 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26610008 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.26199483 |
| 123 | Prion diseases_Homo sapiens_hsa05020 | 0.23374234 |
| 124 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23178317 |
| 125 | Tight junction_Homo sapiens_hsa04530 | 0.22222094 |
| 126 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.21816676 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21507461 |
| 128 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20810671 |
| 129 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.16170097 |
| 130 | Focal adhesion_Homo sapiens_hsa04510 | 0.16133740 |
| 131 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.14010414 |
| 132 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.11768258 |
| 133 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.11184831 |
| 134 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.09546436 |
| 135 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.09409618 |
| 136 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.09299983 |
| 137 | Amoebiasis_Homo sapiens_hsa05146 | 0.09250438 |
| 138 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.07783444 |
| 139 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.07265049 |
| 140 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.07235936 |
| 141 | Adherens junction_Homo sapiens_hsa04520 | 0.04383104 |
| 142 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.04283318 |
| 143 | Viral myocarditis_Homo sapiens_hsa05416 | 0.03828942 |

